Platelet-derived growth factor (PDGF) mRNA, and mRNA for its receptor, have been localized to specific cell types within the human atherosclerotic plaque, using in situ hybridization. The predominant cell types found to express PDGF A and B chain mRNA are mesenchymal-appearing intimal cells and endotheHal cells, respectively, with little or no expression detected-in macrophages. The distribution of PDGF receptor mRNA containing cells was also examined and found to be localized predominantly in the plaque intima.
Introduction
Platelet-derived growth factor (PDGF)' is a dimer composed of two homologous polypeptide chains, A and B (1, 2) . The genes encoding these polypeptide chains have been mapped to different chromosomes (3, 4) and their expression is independently regulated (3) . The gene encoding PDGF B chain mRNA is c-sis which is the cellular counterpart to the v-sis gene of simian sarcoma virus (5) (6) (7) . PDGF has been hypothesized to be responsible for intimal proliferation in atherosclerosis. This hypothesis originated with the observations that platelets contain a mitogen for smooth muscle and that platelets accumulate and release their granules at sites of endothelial denudation (8, 9) . The source of PDGF was therefore presumed to be external to the vessel wall, in the form of blood borne platelets. A requirement for platelets, however, could not explain certain experimental observations. With hypercholesterolemia, smooth muscle proliferation can precede the loss ofendothelium (10) . In hypertension, smooth muscle replication occurs without recognizable endothelial denudation (11) (12) (13) (14) . Finally, in the balloon-injured rat carotid artery, smooth muscle proliferation continues long after most of the platelet interaction with the vessel wall has ceased (15) (16) (17) .
Subsequent studies in PDGF biology revealed that many cell types, including macrophages (18) (19) (20) (21) , endothelial cells (22) (23) (24) and even arterial smooth muscle cells (25-27) can produce PDGF, at least in vitro. Since these same cell types are present in human atherosclerotic plaques (28, 29), the PDGF hypothesis of atherogenesis has been modified to include the possible production of PDGF from within the developing human intima (30) . Indeed, local synthesis of PDGF in the atheroma is supported by recent studies showing that PDGF B chain mRNA can be detected by Northern blots of human carotid plaques removed at surgery (31) .
In the present series of experiments we report the first successful detection of PDGF gene expression within the human atherosclerotic plaque by in situ hybridization.
Methods
In situ hybridizations. In situ hybridizations were carried out as described previously (32) (33) (34) (35) . Human carotid endarterectomy specimens were obtained from surgery and within 15 min of removal fixed in 4% paraformaldehyde 0.1 M sodium phosphate buffer for 3-18 h at 40C followed by immersion in sterile 15% sucrose PBS overnight at 40C.
The tissue was then frozen in O.C.T. (Miles Scientific, Elkhart, IN) and 7 gm frozen sections thaw-mounted onto polylysine-coated slides and stored at -70'C with desiccant. Before hybridization the sections were pretreated with paraformaldehyde (10 min) and proteinase K (1 ,ug/ml) (10 min), prehybridized for 1-2 h in 50 Ml of prehybridization buffer (0.3 M NaCl, 20 mM Tris pH8.0, 5 mM EDTA, i X Denhardt's solution, 10% dextran sulfate, and 10 mM DTT). The hybridizations were started by adding 300,000 cpm ofthe "5S-riboprobe in a small amount of prehybridization buffer. After hybridization the sections were washed with 2X SSC (2 X 10 min) (1X SSC = 150 mM NaCl, 15 
Results
Expression of PDGF and PDGF receptor mRNA by plaque regions. Serial 10-,m sections of eight human carotid atherosclerotic plaques removed at surgery were hybridized to 35S-labeled PDGF A-or B-chain-specific cRNA probes. The most immediately impressive result was the recognition at low magnification that the mRNAs for both chains of PDGF were distributed nonrandomly within the plaque, and involved a subset of cells. Based on cell counts performed on random sections of four carotid plaques 7.2% of all plaque cells counted (308/4306 cells) showed hybridization for B-chain and 15.2% (669/4405 cells) revealed PDGF A-chain hybridization. Similarly 6.5% of all cells (251/3888 cells) revealed PDGF receptor hybridization.
Cells containing mRNA encoding both PDGF A and B chains could be detected in similar locations in the plaque (Fig.  1, A and B) . Cells containing the mRNA for the B-chain of PDGF were most prominent at the lumenal edges of vascular structures and in plaque regions rich in small, penetrating blood vessels (Fig. 1 B) . Cells containing the mRNA for the A chain of PDGF were found over similar vascularized plaque regions ( Fig. 1 A) but also over sparsely distributed mesenchymal-appearing intimal cells distributed in the fibrous portions of the plaque ( We used multiple probes to confirm the specificity of the hybridization reaction and to control for the possibility that hybridizations at tissue edges could represent a form of edge artefact. Serial sections from every experiment were hybridized with 35S-labeled cRNAs to: PDGF A, PDGF B, PDGF receptor, or to transforming growth factor-alpha (TGF-a). These probes were all labeled to the same specific activity and equivalent amounts of each radioactive probe were added to the hybridization reactions. Each probe gave distinct, different patterns of hybridization. Positive autoradiography was not seen at the cut edges of the media or plaque using the TGF-a or PDGF receptor probes. In no case was positive TGF-a hybridization seen on any vascular section examined, and so this probe served as a negative control for every hybridization. The TGF-a probe was however effective in labeling epidermal cells in normal human skin using the same methodology (46) .
As already noted, we observed a strong correlation between those plaque regions making PDGF B-chain mRNA and the intraplaque capillaries. Examination of this tissue at higher magnification suggested that endothelial cells were a major site of PDGF B-chain synthesis since positive cells were found at the luminal surfaces (Fig. 2) . Serial sections stained with antivWf or Ulex Europaeus lectin confirmed that endothelial cells were present at the luminal surfaces of these vascular profiles.
Serial sections hybridized with A-chain specific probes showed less intense labeling of endothelial cells. However, some vascular profiles appeared to express both A and B chains (Fig. 2) . More often, A-chain hybridization was found in cells adjacent to the endothelium in the capillary wall (Fig. 2  D) or in mesenchymal-appearing intimal cells (Fig. 3) . Only occasional endothelial-appearing cells displayed A-chain hybridization, whereas most of such cells displayed B-chain hybridization.
Not all plaque capillary profiles expressed PDGF. More plaque capillaries could be identified by reactivity to anti-vWf antibody or with the Ulex Europaeus lectin than were positive by in situ hybridization for either PDGF A-or B-chain mRNA. To control for the possibility that not all endothelial cells had mRNA available for hybridization, some serial sections were hybridized with the oligomer directed against vWf mRNA tailed with [35S]CTP. A comparison of this in situ vWf labeling to that of PDGF B chain confirmed that there were more capillary endothelial-appearing cells containing vWf mRNA than PDGF B-chain mRNA supporting our hypothesis that there is a subset of endothelial cells making PDGF B chain mRNA.
PDGF B chain mRNA was also detected in endothelial cells of normal internal mammary artery (Fig. 2 E) . In these same internal mammary artery specimens, little hybridization was seen with the PDGF A-chain probe (Fig. 2 F) or the PDGF receptor probe, and none was seen with the TGF-a probe (results not shown). The background was very low for all of these probes, confirming the specificity of our result to the B chain of PDGF. Few (if any) to local PDGF production in the atherosclerotic plaque (Fig. 4) . Similarly, no positive hybridizations to either PDGF chain were seen among lymphocyte-appearing cells (Fig. 3 A, Table I ). Although by autoradiographic grain intensity, B-chain hybridization was most intense among the endothelial-appearing cells of plaque capillaries, the largest number cells positively hybridized for B-and A-chain were noncapillary, mesenchymal-appearing intimal cells (Table I) . Some of these cells had the light microscopic appearance of smooth muscle cells, i.e., spindle-shaped cells with long, slender nuclei (Fig. 3 B) (47) .
Many more cells had a stellate shape and displayed variable amounts of cytoplasm (Fig. 3 A) . However, most ofthe stellate cells did not stain well with any of the cell type-specific antibodies used. Thus the identity ofthese cells remains somewhat unclear.
Localization ofPDGF receptor to the arterial intima. All of the samples so far discussed were hybridized in parallel with PDGF receptor probe as well. Many cells in the intima of the plaque make mRNA for PDGF receptor (Fig. 5 B) . Again, almost all such cells had the same mesenchymal morphology as described above for the majority of A-and B-chain positive cells. No lymphocyte-appearing cells, no endothelial-appearing cells, and almost no foam cells or hemosiderin-containing cells were positive for PDGF receptor. Similarly, by serial section immunocytochemistry analysis, PDGF receptor positive cells did not appear to react with monocyte/macrophage or lymphocyte antibodies, nor did they show Ulex Europaeus binding. PDGF receptor positive cells were distributed in regions previously seen to be A-or B-chain positive. In one sample of coronary artery taken from a diseased heart removed during transplant surgery we found a diffuse intimal thickening without atherosclerotic change, and with no evidence of macrophages or T cells. This sample was hybridized with the PDGF receptor probe and displayed prominent labeling of the intimal cells (Fig. 5 A) . Few PDGF receptor positive cells were identified in the media of both this coronary artery specimen and carotid plaques.
Discussion
Our data using in situ hybridization corroborate existing data in demonstrating that PDGF mRNA is expressed in athero-.% A* V.V Figure 4 . Demonstration that macrophages do not make PDGF A chain mRNA in the human atherosclerotic plaque by simultaneous in situ hybridization and immunocytochemistry. Frozen sections were hybridized as described using the 35S-labeled PDGF A specific riboprobe. After the posthybridization washes the tissue was stained by immunocytochemistry using the HAM56 antibody as described followed by dehydration and coating with emulsion. In preliminary studies it was found that the prior processing of the tissue by the in situ procedure intensified subsequent immunostaining. X3 10. sclerotic plaques. Expression of PDGF receptor, and its selective expression by the intimal mesenchymal cell, and not medial smooth muscle cells, establishes the presence ofa target for this agonist in the part ofthe vessel known to undergo selective proliferation in atherosclerosis. We have no direct evidence that the PDGF produced in the plaque is stimulating replication. There are almost no data on proliferation occurring in human arterial tissue. The studies that have been performed using either in vitro thymidine labeling or flow cytometry have revealed labeling indices of < 0.1% (57) (58) (59) . Aside from being a mitogen, PDGF has other properties, including inducing chemotaxis and contraction ofsmooth muscle cells (60) (61) (28, 29, 62) . The usual conclusion has been that these cells are altered smooth muscle cells, since this cell type is believed to be the sole connective tissue cell comprising the inner tunica media from which the intimal cells are hypothesized to arise (30) . Whatever its cell lineage, this cell comprises a large portion of the human atherosclerotic intima and appears to be responsible for most of the local PDGF A chain production.
One of the most striking features of atherosclerosis has been the localization of proliferating smooth muscle cells to the intima. Martin (65) proposed that this depends on loss of contact dependent control of growth by sparsely scattered smooth muscle cells in the intima. Benditt proposed that atherosclerosis represents a monoclonal, neoplastic growth at sites of high mutagen accumulation due to lipid deposition (49, 50) . Ross and others have proposed that localization of proliferating smooth muscle cells depends on accumulation of toxic or stimulatory products along a permeability gradient (30) . None of these ideas suggest the special properties that make intimal smooth muscle cells proliferate. The focal nature ofexpression of A chain mRNA by the scattered mesenchymal-appearing intimal cells and the localization of receptor expression to the intima may be important clues to identifying the special properties of intimal smooth muscle cells that may contribute to the development of the atherosclerotic plaque.
